Ubiquitin Builds Up An Immune Response
Main Category: Immune System / VaccinesAlso Included In: Biology / Biochemistry; Genetics
Article Date: 22 Oct 2007 - 0:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
2.5 (2 votes) |
The acquired immune response is triggered after specific engagement of foreign peptides (antigens) by receptor molecules on white blood cell (lymphocytes). Cellular signaling pathways are responsible for the activation of lymphocytes. Krappmann and co-workers present evidence, that in T cells, which constitute a subgroup of lymphocytes, ubiquitin is attached to the Malt1 protein in response to antigen stimulation. Malt1 is part of the CBM (Carma1-Bcl10-Malt1) complex that constitutes a crucial switch for the activation of the immune defense. Using biochemical, molecular and genetic techniques the scientists could prove that this novel Malt1 ubiquitination is an essential step in the regulation of T cell activation.
'Mechanistically, ubiquitin is virtually acting as all-purpose glue that links different protein components inside the cell', Krappmann explains. 'However, ubiquitination provides an important advantage compared to conventional adhesives: It is reversible, meaning that the associations can be resolved'.
This process of de-ubiquitination is constantly happening in cells and it could contribute to prevent an over-shooting activation of T cells. Unopposed lymphocyte activity is responsible for many chronic diseases, autoimmunity or even lymphoma development. Future work must address the status of Malt1 ubiquitination under pathological conditions, for instance in Malt1 dependent lymphomas. By this the scientists hope to demonstrate the potential of targeting the ubiquitin system for the development of novel therapeutic approaches.
###
Publication:
Oeckinghaus, A., Wegener, E, Welteke, V., Ferch, U., Çöl Arslan, S., Ruland, J., Scheidereit, C. and Krappmann, D. (2007) Malt1 ubiquitination triggers IKK/NF-κB signalling upon T cell activation. EMBO J.; AOP; 18th of Oct. 2007; doi: 10.1038/sj.emboj.7601897
Contact:
GSF - Forschungszentrum für Umwelt und Gesundheit
Corporate Communications
Source: Heinz Joerg Haury
GSF - National Research Center for Environment and Health
Visit our immune system / vaccines section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/86203.php>
APA
http://www.medicalnewstoday.com/releases/86203.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




